Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 10061

Sacramento, CA 95821

Study Summary:

ZA-202, NCT01191320:A randomized, parallel, double-blind, placebo-controlled exploratory study to evaluate the efficacy of androxal® in improving glycemic control in men with secondary hypogonadism or adult-onset idiopathic hypogonadotropic hypogonadism (aihh) and type 2 diabetes mellitus with sub-optimum treatment.

Qualified Participants Must:

• Be 20 to 80- years of age, inclusive
• Be diagnosed with type II diabetes mellitus for at least 6 months
• Be on stable diabetes medications for a minimum of 2 months
• Have untreated, but, previously diagnosed secondary hypogonadism and low testosterone or has symptoms of secondary hypogonadism and low testosterone

Qualified Participants May Receive:

Study related medical care, medication and may be compensated for their participation.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.